Education
About Us
Working with TipRanks
Follow Us
Windtree Therapeutics (WINT)
NASDAQ:WINT
RESEARCH TOOLSreports
Total Valuation
Windtree Therapeutics has a market cap or net worth of $2.74M. The enterprise value is $3.26M.
Market Cap$2.74M
Enterprise Value$3.26M
Share Statistics
Windtree Therapeutics has 3,661,289 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,661,289
Owned by Insiders0.71%
Owned by Institutions<0.01%
Financial Efficiency
Windtree Therapeutics’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -328.22%.
Return on Equity (ROE)-0.55
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-328.22%
Return on Capital Employed (ROCE)-1.13
Revenue Per Employee0.00
Profits Per Employee-127.64K
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Windtree Therapeutics is -0.17. Windtree Therapeutics’s PEG ratio is <0.01.
PE Ratio-0.17
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value0.09
Price to FCF-0.20
Price to Operating Cash Flow>-0.01
PEG Ratio<0.01
Income Statement
In the last 12 months, Windtree Therapeutics had revenue of 0.00 and earned -5.49M in profits. Earnings per share was -104.35.
Revenue0.00
Gross Profit0.00
Operating Income-25.02M
Pretax Income-1.79M
Net Income-5.49M
EBITDA0.00
Earnings Per Share (EPS)-104.35
Cash Flow
In the last 12 months, operating cash flow was -14.86M and capital expenditures -12.00K, giving a free cash flow of -14.87M billion.
Operating Cash Flow-14.86M
Free Cash Flow-14.87M
Free Cash Flow per Share-4.06
Dividends & Yields
Windtree Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.61
52-Week Price Change-99.60%
50-Day Moving Average1.22
200-Day Moving Average75.32
Relative Strength Index (RSI)30.89
Average Volume (3m)226.82K
Important Dates
Windtree Therapeutics upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 16, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
Windtree Therapeutics as a current ratio of 0.45, with Debt / Equity ratio of 136.03%
Current Ratio0.45
Quick Ratio0.45
Debt to Market Cap1.43
Net Debt to EBITDA0.00
Interest Coverage Ratio-106.46
Taxes
In the past 12 months, Windtree Therapeutics has paid 3.69M in taxes.
Income Tax3.69M
Effective Tax Rate-2.06
Enterprise Valuation
Windtree Therapeutics EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -0.06.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow-0.06
EV to Operating Cash Flow-0.06
Balance Sheet
Windtree Therapeutics has $1.17M in cash and marketable securities with $1.41M in debt, giving a net cash position of $239.00K billion.
Cash & Marketable Securities$1.17M
Total Debt$1.41M
Net Cash$239.00K
Net Cash Per Share$0.07
Tangible Book Value Per Share-$268.79
Margins
Gross margin is 46.67%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin46.67%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Windtree Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast97.84%